[ALLIANZ] YoY Cumulative Quarter Result on 31-Dec-2009 [#4]

Stock
[ALLIANZ] ALLIANZ MALAYSIA BHD
Announcement Date
25-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
QoQ- 102.6%
YoY- 68.05%
Quarter Report
Latest QR
Upcoming QR
ALLIANZ's Result
ALLIANZ's Financial Summary
View:
Show?
Cumulative Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 3,147,599 2,751,664 2,509,037 2,221,616 1,898,867 1,445,366 1,133,965 18.53%
PBT 297,779 248,791 191,550 176,969 112,311 12,263 50,279 34.47%
Tax -90,174 -85,155 -62,350 -58,112 -41,583 -14,873 -15,318 34.33%
NP 207,605 163,636 129,200 118,857 70,728 -2,610 34,961 34.53%
-
NP to SH 207,605 163,636 129,200 118,857 70,728 -2,610 34,961 34.53%
-
Tax Rate 30.28% 34.23% 32.55% 32.84% 37.02% 121.28% 30.47% -
Total Cost 2,939,994 2,588,028 2,379,837 2,102,759 1,828,139 1,447,976 1,099,004 17.80%
-
Net Worth 1,821,509 1,614,960 1,260,149 504,661 387,719 320,295 336,695 32.46%
Dividend
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Div 10,206 8,097 5,385 3,077 3,077 3,079 27,427 -15.17%
Div Payout % 4.92% 4.95% 4.17% 2.59% 4.35% 0.00% 78.45% -
Equity
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Net Worth 1,821,509 1,614,960 1,260,149 504,661 387,719 320,295 336,695 32.46%
NOSH 157,026 154,246 153,864 153,860 153,856 153,988 153,742 0.35%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin 6.60% 5.95% 5.15% 5.35% 3.72% -0.18% 3.08% -
ROE 11.40% 10.13% 10.25% 23.55% 18.24% -0.81% 10.38% -
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 2,004.50 1,783.94 1,630.68 1,443.92 1,234.18 938.62 737.58 18.11%
EPS 132.21 106.09 83.97 77.25 45.97 -1.70 22.74 34.05%
DPS 6.50 5.25 3.50 2.00 2.00 2.00 17.84 -15.47%
NAPS 11.60 10.47 8.19 3.28 2.52 2.08 2.19 31.99%
Adjusted Per Share Value based on latest NOSH - 153,865
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 1,767.48 1,545.15 1,408.91 1,247.51 1,066.28 811.62 636.76 18.53%
EPS 116.58 91.89 72.55 66.74 39.72 -1.47 19.63 34.53%
DPS 5.73 4.55 3.02 1.73 1.73 1.73 15.40 -15.17%
NAPS 10.2284 9.0685 7.0762 2.8338 2.1772 1.7986 1.8907 32.46%
Price Multiplier on Financial Quarter End Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 29/12/06 -
Price 7.05 4.75 4.49 4.06 2.90 5.25 6.65 -
P/RPS 0.35 0.27 0.28 0.28 0.23 0.56 0.90 -14.55%
P/EPS 5.33 4.48 5.35 5.26 6.31 -309.75 29.24 -24.68%
EY 18.75 22.33 18.70 19.03 15.85 -0.32 3.42 32.75%
DY 0.92 1.11 0.78 0.49 0.69 0.38 2.68 -16.30%
P/NAPS 0.61 0.45 0.55 1.24 1.15 2.52 3.04 -23.46%
Price Multiplier on Announcement Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 22/02/13 24/02/12 25/02/11 25/02/10 26/02/09 29/02/08 26/02/07 -
Price 7.60 4.98 5.02 4.80 2.80 3.50 6.65 -
P/RPS 0.38 0.28 0.31 0.33 0.23 0.37 0.90 -13.37%
P/EPS 5.75 4.69 5.98 6.21 6.09 -206.50 29.24 -23.72%
EY 17.40 21.30 16.73 16.09 16.42 -0.48 3.42 31.11%
DY 0.86 1.05 0.70 0.42 0.71 0.57 2.68 -17.24%
P/NAPS 0.66 0.48 0.61 1.46 1.11 1.68 3.04 -22.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment